| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director, 10% Owner | Chief Executive Officer +1 more
4 companies
Davis Todd C is a Director, 10% Owner at PTHS with holdings across 4 companies. Recent SEC Form 4 filings include 6 buys and 7 sells.
Estimated insider holdings value: $71.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 9, 2025 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Buy | 9,510 | $105.20 | $1,000,456.37 | +2.1% | +40.0% | - | |
| Aug 8, 2024 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Buy | 2,500 | $97.39 | $243,480.50 | +2.1% | +20.6% | +54.8% | |
| Sep 22, 2023 | LGND Ligand Pharmaceuticals Inc | Chief Executive Officer | Buy | 4,000 | $59.38 | $237,528.80 | +5.8% | +19.9% | +74.0% | |
| Feb 10, 2021 | LGND Ligand Pharmaceuticals Inc | Director | Sale+OE | 5,083 | $213.14 | $1,083,409.94 | -9.6% | - | - | |
| Apr 28, 2020 | VXRT Vaxart, Inc. | Director | Sell | 60,000 | $3.28 | $196,500.00 | -33.3% | - | - | |
| Aug 2, 2019 | LGND Ligand Pharmaceuticals Inc | Director | Buy | 1,000 | $93.59 | $93,594.40 | +2.1% | - | - | |
| Oct 8, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 2,500 | $253.99 | $634,978.00 | -5.5% | - | - | |
| Aug 17, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 9,000 | $239.78 | $2,158,001.77 | -8.8% | - | - | |
| Feb 27, 2018 | LGND Ligand Pharmaceuticals Inc | Director | Sell | 17,170 | $152.37 | $2,616,244.31 | -12.6% | - | - |